Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

SARS-CoV-2: Finding the New Normal— A Diagnostic Perspective

Learning objectives:

 - SARS-CoV-2 science update

 - Impact of COVID-19 on patient health

 - Virus mitigation tools and getting back to life

 

Date:
Jun 22, 2021
Presenter(s):

Hema Kapoor, MD, SM, D(ABMM)

Harvey Kaufman, MD, FCAP, MBA

Jay Wohlgemuth, MD

William III Meyer, PhD, D(ABMM), MLS(ASCP)CM

Related content

Publication
Risk of and duration of protection from SARS CoV 2 reinfection assessed with real world data
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Risk estimation of severe COVID-19 based on initial biomarker assessment across racial and ethnic groups
Publication
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022
Conference Presentation
Coinfection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus
Conference Presentation
Immunocompetent and Immunocompromised Cancer Populations: Post-vaccination Humoral and Cellular Immune Responses Against SARS-CoV-2
Conference Presentation
Correlates of immunity in SARS-CoV-2 post-vaccine infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
Publication
Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results From a Longitudinal Cohort Study
Publication
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
Test FAQ
SARS CoV 2 Antibody Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.